Literature DB >> 9922778

[Concomitant chemoradiotherapy of infiltrating cancers of the bladder].

M Housset1.   

Abstract

Until now, radical cystectomy has been considered the most effective treatment for invasive bladder cancer. However it fails to cure more than 50% of patients and can result in a mediocre quality of life. In an effort to improve cure rates, combined modality regimens have been investigated. Despite the preliminary results of early clinical trials, randomized trials have most often failed to show any benefit from neoadjuvant or adjuvant chemotherapy or radiotherapy. One of the major progress brought by radiotherapy has been the wide use of conservative treatment in several cancer, and in the recent years promising results have been published with concomitant radio-chemotherapy. The use of conservative approach in bladder cancer now appears to be a tangible reality for selected patients, but this combined modality have not yet been tested in randomized trials.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9922778     DOI: 10.1016/s1278-3218(99)80013-4

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival.

Authors:  Cheng-Yen Lee; Kai-Lin Yang; Hui-Ling Ko; Rong-Yau Huang; Pei-Pin Tsai; Ming-Tsun Chen; Yi-Chia Lin; Thomas I-Sheng Hwang; Guang-Dar Juang; Kwan-Hwa Chi
Journal:  Radiat Oncol       Date:  2014-09-24       Impact factor: 3.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.